Overweight and obese adults using popular diabetes medications to suppress their appetites are “significantly more likely” to shed pounds with Eli Lilly’s Mounjaro than with Novo Nordisk’s Ozempic, a new study has found, a result that could have major implications for one of the hottest new markets in the pharmaceutical field.
AuthorFirst Born FilmsNeil Harbisson, who sees in black and white, says his antennae lets him “hear” colourFor the past 20 years, self-declared “cyborg artist” Neil Harbisson has provoked debate with…
AuthorA rare parasitic infection known as raccoon roundworm has been confirmed in Los Angeles, according to the Los Angeles County Department of Public Health.Two people in the South Bay area…
